Skip to content

Evaluation of the Effect of intravenous paracetamol on perioperative pain in coronary artery bypass graft surgery

Evaluation of the Effect of intravenous paracetamol on perioperative pain in coronary artery bypass graft surgery - Intravenous paracetamol and surgical pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000019389
Enrollment
110
Registered
2015-11-16
Start date
2014-01-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative pain in coronary artery bypass graft surgery

Interventions

In paracetamol group 15 minutes before induction of anesthesia 1 g intravenous paracetamol in 50 cc normal saline solution was infused to the patient within 15 minutes. Next dose of paracetamol was

Sponsors

Isfahan university of medical sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria for the study were: undergoing elective surgery CABG, the individual agreement to participate in the study, age 40 to 70 years, not having liver failure (Serum bilirubin greater than 1.8 mg per deciliter and aspartate and alanine aminotransfraz more than 1.5 times of the upper limit of normal), not having renal failure (serum creatinine greater than 2 mg per deciliter), not addictive to opioid drugs and psychotropic substances, and having cardiac ejection fraction greater than 30%.,

Exclusion criteria

Exclusion criteria: Excessive bleeding after surgery (more than 150 ml for the first two hours), having other surgeries in addition to coronary artery bypass surgery such as repair or replacement of heart valves, repeated surgery, and the need for aortic balloon support.

Design outcomes

Primary

MeasureTime frame
Preemptive administration of paracetamol and continue to be administered in the postoperative treatment with prescription of opioids drugs will improved quality of pain control after coronary artery bypass surgery.

Secondary

MeasureTime frame
1- the potency is not enough to reduce the need for narcotics and sedatives drugs and eliminate their side effects. 2- no additional liver damages 3- Hemodynamic stability

Countries

Asia(except Japan)

Contacts

Public ContactMojtaba mansouri

Isfahan university of medical sciences Anesthesiology and Critical Care Research Center, Department of Anesthesiology

mansouri@med.mui.ac.ir+81-098-9133101348

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026